0001193125-23-267306.txt : 20231031 0001193125-23-267306.hdr.sgml : 20231031 20231031171000 ACCESSION NUMBER: 0001193125-23-267306 CONFORMED SUBMISSION TYPE: 20-F/A PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20231031 DATE AS OF CHANGE: 20231031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellectis S.A. CENTRAL INDEX KEY: 0001627281 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36891 FILM NUMBER: 231365623 BUSINESS ADDRESS: STREET 1: 8 RUE DE LA CROIX JARRY CITY: PARIS, LLE-DE-FRANCE STATE: I0 ZIP: 75013 BUSINESS PHONE: 33181691600 MAIL ADDRESS: STREET 1: 8 RUE DE LA CROIX JARRY CITY: PARIS, LLE-DE-FRANCE STATE: I0 ZIP: 75013 20-F/A 1 d566770d20fa.htm 20-F/A 20-F/A
Table of Contents
FY0001627281 0001627281 2022-01-01 2022-12-31 0001627281 2022-12-31 0001627281 dei:AdrMember 2022-01-01 2022-12-31 0001627281 dei:BusinessContactMember 2022-01-01 2022-12-31 xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
20-F/A
(Amendment No. 1)
 
 
(Mark One)
☐
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) or (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
 
☒
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended
December 31, 2022
OR
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
 
☐
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
          
For the transition period from
      
to
        
Commission file number
001-36891
 
 
CELLECTIS S.A.
(Exact name of Registrant as specified in its charter)
 
 
(Translation of Registrant’s name into English)
 
 
France
(Jurisdiction of incorporation or organization)
Cellectis S.A.
8, rue de la Croix Jarry
75013 Paris, France
(Address of principal executive office)
Marie-Bleuenn Terrier
General Counsel
Cellectis S.A.
8, rue de la Croix Jarry
75013 Paris, France
Tel: +33 (0)1 81 69 16 00, Fax: +33 (0)1 81 69 16 06
Securities registered pursuant to Section 12(b) of the Act.
 
Title of each class
  
Trading Symbol
  
Name of each exchange on which registered
American Depositary Shares, each representing one American Depository Shares, each representing one
  
“CLLS”
  
Nasdaq Global Market
Ordinary shares, nominal value €0.05 per share*
    
Nasdaq Global Market*
 
*
Not for trading, but only in connection with the registration of the American Depositary Shares.
Securities registered pursuant to Section 12(g) of the Act.
None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.
None
 
 
Indicate the number of outstanding shares of common stock as of the close of the period covered by the annual report.
Ordinary shares, nominal value €0.05 per share: 45,675,968 as of December 31, 2022
 
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒
If this report is an annual or transition report, indicate by check mark, if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes ☐ No ☒
Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, accelerated filer, a
non-accelerated
filer, or an emerging growth company. See definition of “large accelerated filer”, “accelerated filer” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☒
Non-accelerated
file		   ☐    Emerging Growth Company   ☐
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. ☐
† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included on the filing reflect the correction of an error to previously issued financial statements ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to
§
240.10D-1(b). ☐
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
 
U.S. GAAP ☐   
International Financial Reporting Standards as issued
by the International Accounting Standards Board ☒
    Other ☐
If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow: Item 17 ☐ Item 18 ☐
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange
Act). Yes ☐ No ☒
(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. ☐ Yes ☐ No
 
Auditor Firm Id: 1704    Auditor Name: Ernst & Young et Autres    Auditor Location: Courbevoie, France
 
 
 

Table of Contents

TABLE OF CONTENTS

 

         PAGE  

EXPLANATORY NOTE

      1  

PART II

   

Item 16G.

  

Corporate Governance

      2  

PART III

   

Item 19.

  

Exhibits

      3  

Table of Contents
true
EXPLANATORY NOTE
This Amendment No. 1 on Form
 
20-F/A
 
(this “Amendment”) amends the Annual Report on Form
 
20-F
 
of Cellectis S.A. and its consolidated subsidiaries (the “Company”) for the year ended December 31, 2022, which was filed with the Securities and Exchange Commission on March 14, 2023 (the “Original Filing”).
The Company is filing this Amendment solely for the purpose of updating the disclosure in Item 16G of Part II of the Original Filing. In accordance with Rule
 
12b-15
 
promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Item 16G of Part II of the Original Filing is hereby amended and restated in its entirety. In addition, pursuant to Rule
 
12b-15
 
under the Exchange Act, the Company is including new certifications by the Company’s principal executive officer and principal financial officer as exhibits to this Amendment pursuant to Rule
 
13a-14(a)
 
of the Exchange Act. Because no financial statements have been included in this Form
 
20-F/A
 
and this Form
 
20-F/A
 
does not contain or amend any disclosure with respect to Item 15, paragraphs 3, 4 and 5 of the certifications have been omitted. Except as described above or as otherwise expressly provided by the terms of this Amendment, no other changes have been made to the Original Filing. Except as otherwise indicated herein, this Amendment continues to speak as of the date of the Original Filing, and the Company has not updated the disclosures contained therein to reflect any events that occurred subsequent to the date of the Original Filing.
 
1

Table of Contents

PART II

 

ITEM 16G.

CORPORATE GOVERNANCE

As a French société anonyme, we are subject to various corporate governance requirements under French law. In addition, as a foreign private issuer listed on the Nasdaq Global Market, we will be subject to the Nasdaq corporate governance listing standards. However, the Nasdaq Global Market’s listing standards provide that foreign private issuers are permitted to follow home country corporate governance practices in lieu of the Nasdaq rules, with certain exceptions. Certain corporate governance practices in France may differ significantly from Nasdaq’s corporate governance listing standards. For example, neither the corporate laws of France nor our By-laws require that (i) a majority of our directors be independent, (ii) our compensation committee include only independent directors, or (iii) our independent directors hold regularly scheduled meetings at which only independent directors are present. Other than as set forth below, we currently intend to comply with the corporate governance listing standards of Nasdaq to the extent possible under French law. However, we may choose to change such practices to follow home country practice in the future.

Although we are a foreign private issuer, we are required to comply with Rule 10A-3 of the Exchange Act, relating to audit committee composition and responsibilities. Rule 10A-3 provides that the audit committee must have direct responsibility for the nomination, compensation and choice of our auditors, as well as control over the performance of their duties, management of complaints made, and selection of consultants. Under Rule 10A-3, if the laws of a foreign private issuer’s home country require that any such matter be approved by the board of directors or the shareholders of the Company, the audit committee’s responsibilities or powers with respect to such matter may instead be advisory. Under French law, the audit committee may only have an advisory role and appointment of our statutory auditors, in particular, must be decided by our shareholders at our annual meeting.

Nasdaq rules require that a listed company specify that the quorum for any meeting of the holders of share capital be at least 331⁄3% of the outstanding shares of the company’s common voting stock. We follow our French home country practice, rather than complying with this Nasdaq rule. Consistent with French Law, our By-laws provide that when first convened, general meetings of shareholders may validly convene only if the shareholders present or represented hold at least (1) 20% of the voting shares in the case of an ordinary general meeting or of an extraordinary general meeting where shareholders are voting on a capital increase by capitalization of reserves, profits or share premium, or (2) 25% of the voting shares in the case of any other extraordinary general meeting. If such quorum required by French law is not met, the meeting is adjourned. There is no quorum requirement under French law when an ordinary general meeting or an extraordinary general meeting where shareholders are voting on a capital increase by capitalization of reserves, profits or share premium is reconvened, but the reconvened meeting may consider only questions that were on the agenda of the adjourned meeting. When any other extraordinary general meeting is reconvened, the required quorum under French law is 20% of the shares entitled to vote. The reconvened meeting may consider only questions that were on the agenda of the adjourned meeting. If a quorum is not met at a reconvened meeting requiring a quorum, then the meeting may be adjourned for a maximum of two months.

Finally, we follow French law with respect to shareholder approval requirements in lieu of the various shareholder approval requirements of Nasdaq Rule 5635, which requires a Nasdaq listed company to obtain shareholder approval prior to certain issuances of securities, including: (a) issuances in connection with the acquisition of the stock or assets of another company if upon issuance the issued shares will equal 20% or more of the number of shares or voting power outstanding prior to the issuance, or if certain specified persons have a 5% or greater interest in the assets or company to be acquired (Rule 5635(a)); (b) issuances or potential issuances that will result in a change of control of us (Rule 5635(b)); (c) issuances in connection with equity compensation arrangements (Rule 5635(c)); and (d) 20% or greater issuances in transactions other than public offerings, as defined in the Nasdaq rules (Rule 5635(d)). Under French law, our shareholders may approve issuances of equity, as a general matter, through the adoption of delegation of authority resolutions at the Company’s shareholders’ meeting pursuant to which shareholders may delegate their authority to the Executive Board to increase the Company’s share capital within specified parameters set by the shareholders, which may include a time limitation to carry out the share capital increase, the cancellation of their preferential subscription rights to the benefit of named persons or a category of persons, specified price limitations and/or specific or aggregate limitations on the size of the share capital increase. Due to differences between French law and corporate governance practices and Nasdaq Rule 5635, we follow our French home country practice, rather than complying with this Nasdaq rule.

In accordance with French law, committees of our board of directors will only have an advisory role and can only make recommendations to our board of directors. As a result, decisions will be made by our board of directors taking into account nonbinding recommendations of the relevant board committee.

 

2

Table of Contents

PART III

Exhibit Index

The following exhibits are filed as part of this Annual Report:

 

Exhibit
Number

   

Description of Exhibit

   

Schedule/

 Form 

   

File Number

   

Exhibit

   

File Date

12.1

    Certificate of Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002             Filed herewith

12.2

    Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002             Filed herewith

104.1

    Cover Page Interactive Data File (formatted as Inline XBRL)             Filed herewith

 

3

Table of Contents

SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F/A and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

 

CELLECTIS S.A.

/s/ André Choulika

By: André Choulika
Title: Chairman and Chief Executive Officer

Date: October 31, 2023

EX-12.1 2 d566770dex121.htm EX-12.1 EX-12.1

Exhibit 12.1

Certification by the Principal Executive Officer pursuant to

Securities Exchange Act Rules 13a-14(a) and 15d-14(a)

as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, André Choulika, certify that:

 

  1.

I have reviewed this annual report on Form 20-F/A of Cellectis S.A.; and

 

  2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: October 31, 2023

 

/s/ André Choulika

Name:

  

André Choulika

Title:

  

Chief Executive Officer (Principal Executive Officer)

 EX-12.2 3 d566770dex122.htm EX-12.2 EX-12.2

Exhibit 12.2

Certification by the Principal Financial Officer pursuant to

Securities Exchange Act Rules 13a-14(a) and 15d-14(a)

as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Bing Wang, certify that:

 

  1.

I have reviewed this annual report on Form 20-F/A of Cellectis S.A.; and

 

  2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: October 31, 2023

 

/s/ Bing Wang

Name:

  

Bing Wang

Title:

  

Chief Financial Officer (Principal Financial Officer)

 EX-101.SCH 4 clls-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 5 clls-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 6 clls-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 7 clls-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 8 clls-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page
 12 Months Ended
Dec. 31, 2022
shares
Document Information [Line Items]  
Document Type 20-F/A
Amendment Flag true
Document Period End Date Dec. 31, 2022
Document Fiscal Year Focus 2022
Document Fiscal Period Focus FY
Entity Registrant Name CELLECTIS S.A.
Entity Central Index Key 0001627281
Current Fiscal Year End Date --12-31
Entity Well-known Seasoned Issuer No
Entity Current Reporting Status Yes
Entity Filer Category Accelerated Filer
Entity Common Stock, Shares Outstanding 45,675,968
Entity Shell Company false
Entity Emerging Growth Company false
Title of 12(b) Security Ordinary shares, nominal value €0.05 per share
Security Exchange Name NASDAQ
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Entity Voluntary Filers No
Entity Interactive Data Current Yes
Entity Address, Country FR
ICFR Auditor Attestation Flag true
Entity Address, Address Line One 8, rue de la Croix Jarry
Entity File Number 001-36891
Entity Incorporation, State or Country Code I0
Entity Address, City or Town Paris
Entity Address, Postal Zip Code 75013
Document Accounting Standard International Financial Reporting Standards
No Trading Symbol Flag true
Auditor Firm ID 1704
Auditor Name Ernst & Young et Autres
Auditor Location Courbevoie, France
Amendment Description This Amendment No. 1 on Form 20-F/A (this “Amendment”) amends the Annual Report on Form 20-F of Cellectis S.A. and its consolidated subsidiaries (the “Company”) for the year ended December 31, 2022, which was filed with the Securities and Exchange Commission on March 14, 2023 (the “Original Filing”).The Company is filing this Amendment solely for the purpose of updating the disclosure in Item 16G of Part II of the Original Filing. In accordance with Rule 12b-15 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Item 16G of Part II of the Original Filing is hereby amended and restated in its entirety. In addition, pursuant to Rule 12b-15 under the Exchange Act, the Company is including new certifications by the Company’s principal executive officer and principal financial officer as exhibits to this Amendment pursuant to Rule 13a-14(a) of the Exchange Act. Because no financial statements have been included in this Form 20-F/A and this Form 20-F/A does not contain or amend any disclosure with respect to Item 15, paragraphs 3, 4 and 5 of the certifications have been omitted. Except as described above or as otherwise expressly provided by the terms of this Amendment, no other changes have been made to the Original Filing. Except as otherwise indicated herein, this Amendment continues to speak as of the date of the Original Filing, and the Company has not updated the disclosures contained therein to reflect any events that occurred subsequent to the date of the Original Filing.
Business Contact [Member]  
Document Information [Line Items]  
Entity Address, Country FR
Contact Personnel Name Marie-Bleuenn Terrier
Entity Address, Address Line One 8, rue de la Croix Jarry
Entity Address, City or Town Paris
Entity Address, Postal Zip Code 75013
City Area Code 33
Local Phone Number 1 81 69 16 00
Contact Personnel Fax Number +33 (0)1 81 69 16 06
American Depositary Shares [member]  
Document Information [Line Items]  
Trading Symbol CLLS
Title of 12(b) Security American Depositary Shares, each representing one American Depository Shares, each representing one
Security Exchange Name NASDAQ
XML 10 d566770d20fa_htm.xml IDEA: XBRL DOCUMENT 0001627281 2022-01-01 2022-12-31 0001627281 2022-12-31 0001627281 dei:AdrMember 2022-01-01 2022-12-31 0001627281 dei:BusinessContactMember 2022-01-01 2022-12-31 shares FY 0001627281 20-F/A false true 2022-12-31 --12-31 2022 false false 001-36891 CELLECTIS S.A. I0 8, rue de la Croix Jarry 75013 Paris FR Marie-Bleuenn Terrier 8, rue de la Croix Jarry 75013 Paris FR 33 1 81 69 16 00 +33 (0)1 81 69 16 06 American Depositary Shares, each representing one American Depository Shares, each representing one CLLS NASDAQ Ordinary shares, nominal value €0.05 per share NASDAQ true 45675968 No No Yes Yes Accelerated Filer false true International Financial Reporting Standards false 1704 Ernst & Young et Autres Courbevoie, France true This Amendment No. 1 on Form 20-F/A (this “Amendment”) amends the Annual Report on Form 20-F of Cellectis S.A. and its consolidated subsidiaries (the “Company”) for the year ended December 31, 2022, which was filed with the Securities and Exchange Commission on March 14, 2023 (the “Original Filing”).The Company is filing this Amendment solely for the purpose of updating the disclosure in Item 16G of Part II of the Original Filing. In accordance with Rule 12b-15 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Item 16G of Part II of the Original Filing is hereby amended and restated in its entirety. In addition, pursuant to Rule 12b-15 under the Exchange Act, the Company is including new certifications by the Company’s principal executive officer and principal financial officer as exhibits to this Amendment pursuant to Rule 13a-14(a) of the Exchange Act. Because no financial statements have been included in this Form 20-F/A and this Form 20-F/A does not contain or amend any disclosure with respect to Item 15, paragraphs 3, 4 and 5 of the certifications have been omitted. Except as described above or as otherwise expressly provided by the terms of this Amendment, no other changes have been made to the Original Filing. Except as otherwise indicated herein, this Amendment continues to speak as of the date of the Original Filing, and the Company has not updated the disclosures contained therein to reflect any events that occurred subsequent to the date of the Original Filing. EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO7W)E M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " ]B5]799!YDAD! #/ M P $P @ $Y& 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 1 "0 ) #X" "#&0 ! end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 4 40 1 false 2 0 false 1 false false R1.htm 1001 - Document - Cover Page Sheet http://www.cellectis.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports clls-20221231.xsd clls-20221231_cal.xml clls-20221231_def.xml clls-20221231_lab.xml clls-20221231_pre.xml d566770d20fa.htm http://xbrl.sec.gov/dei/2022 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d566770d20fa.htm": { "nsprefix": "clls", "nsuri": "http://www.cellectis.com/20221231", "dts": { "schema": { "local": [ "clls-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] }, "calculationLink": { "local": [ "clls-20221231_cal.xml" ] }, "definitionLink": { "local": [ "clls-20221231_def.xml" ] }, "labelLink": { "local": [ "clls-20221231_lab.xml" ] }, "presentationLink": { "local": [ "clls-20221231_pre.xml" ] }, "inline": { "local": [ "d566770d20fa.htm" ] } }, "keyStandard": 40, "keyCustom": 0, "axisStandard": 1, "axisCustom": 1, "memberStandard": 2, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2022": 3 }, "contextCount": 4, "entityCount": 1, "segmentCount": 2, "elementCount": 49, "unitCount": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 46 }, "report": { "R1": { "role": "http://www.cellectis.com/role/CoverPage", "longName": "1001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d566770d20fa.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d566770d20fa.htm", "first": true, "unique": true } } }, "tag": { "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r5", "r6", "r7" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentRegistrationStatement", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityShellCompany", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_AdrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AdrMember", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "ADR [Member]", "verboseLabel": "American Depositary Shares [member]", "documentation": "American Depositary Receipt (or American Depositary Share, ADS)." } } }, "auth_ref": [ "r4" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "LocalPhoneNumber", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityRegistrantName", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFileNumber", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12bTitle", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFilerCategory", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "terseLabel": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentAnnualReport", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r5", "r6", "r7" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "NoTradingSymbolFlag", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AddressTypeDomain", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AuditorLocation", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r5", "r6", "r7" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "TradingSymbol", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentFlag", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AuditorName", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r5", "r6", "r7" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityExchangeName", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r3" ] }, "clls_ClassOfSharesAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.cellectis.com/20221231", "localname": "ClassOfSharesAxis", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Class of shares [Axis]", "documentation": "Class of stock." } } }, "auth_ref": [] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "BusinessContactMember", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r6", "r7" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentShellCompanyReport", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_ContactPersonnelFaxNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "ContactPersonnelFaxNumber", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Fax Number", "documentation": "Fax Number of contact personnel." } } }, "auth_ref": [ "r6" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AuditorFirmId", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r5", "r6", "r7" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentType", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r9" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentAccountingStandard", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r6" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCountry", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentDescription", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentTransitionReport", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r8" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r10" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CityAreaCode", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "clls_ClassOfSharesDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.cellectis.com/20221231", "localname": "ClassOfSharesDomain", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Class Of Shares [Domain]", "documentation": "Class Of Shares." } } }, "auth_ref": [] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "ContactPersonnelName", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentInformationTable", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.cellectis.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d-3" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" } } } ZIP 17 0001193125-23-267306-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-267306-xbrl.zip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